Abstract
Editor's evaluation: Lonafarnib improves cardiovascular function and survival in a mouse model of Hutchinson-Gilford progeria syndrome
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.7554/elife.82728.sa0
Copy DOIPublication Date: Oct 6, 2022 |
License type: CC BY 4.0 |
Editor's evaluation: Lonafarnib improves cardiovascular function and survival in a mouse model of Hutchinson-Gilford progeria syndrome
Join us for a 30 min session where you can share your feedback and ask us any queries you have